retatrutide weight loss study results New Phase 3 data just dropped 👀 Eli Lilly's trial reported average approaching 30%, with some patients achieving historically associated with bariatric surgery. A few important caveats Retatrutide just delivered one of

Donanemab, another controversial drug which costs about 60-80,000 per year, shows a 0.7 point difference at 76 weeks, which is roughly 33% slower than placebo

It is currently known as Triple G , because it activates three hormone receptors (GLP-1, GIP, and Glucagon) to promote weight loss by reducing appetite, improving insulin response, and increasing fat burning

July 10, 2023

A meta-analysis showed that GLP-1RAs could increase lean body mass, cross-sectional area of muscle fibers and grip strength in animal models, enhance the expression of muscle growth factors, and inhibit genes related to muscle atrophy and inflammatory factors [62]

GLP-1/GIP + B12 plays a crucial role in regulating blood sugar and suppressing appetite

Weight loss is a complex and personal process that requires individualized approaches, said Dr